Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea.
ConclusionMutation frequencies and rates should be considered when estimating the POCT usage required to reduce the risk of resistance development in a given population. Molecular POCTs for resistance mutations and stepping-stone mutations to resistance are likely to become important tools in antibiotic stewardship.
PMID: 33124551 [PubMed - in process]
Source: Euro Surveill - Category: Infectious Diseases Authors: Vegvari C, Grad YH, White PJ, Didelot X, Whittles LK, Scangarella-Oman NE, Mitrani-Gold FS, Dumont E, Perry CR, Gilchrist K, Hossain M, Mortimer TD, Anderson RM, Gardiner D Tags: Euro Surveill Source Type: research
More News: Cipro | Ciprofloxacin | Gonorrhoea | Infectious Diseases | International Medicine & Public Health | Middle East Health | Oman Health | PET Scan | UK Health